Suppr超能文献

正常乳腺及癌相关乳腺中导管原位癌的患病率。

The prevalence of carcinoma in situ in normal and cancer-associated breasts.

作者信息

Alpers C E, Wellings S R

出版信息

Hum Pathol. 1985 Aug;16(8):796-807. doi: 10.1016/s0046-8177(85)80251-3.

Abstract

Two hundred ninety-two human breasts were examined in toto by a subgross sampling technique with histologic confirmation. The samples consisted of 185 breasts from random autopsies, 63 cancer-containing breasts, and 44 breasts contralateral to cancer-containing breasts. The method permits the identification and enumeration of essentially all of the dysplastic, hyperplastic, and neoplastic lesions present in each breast. Emphasis was on the prevalence within each sample category of ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS), and epithelial proliferative lesions with severe atypia, previously termed ALA 4 and ALB 4, which correspond to the clinicopathologic entities atypical ductal hyperplasia and atypical lobular hyperplasia, respectively. Additional primary foci of DCIS (unrelated to invasive breast carcinoma, if present) were found in 52.5 per cent of cancer-containing breasts, and were seen in 47.7 per cent of contralateral and 5.9 per cent of the breasts from random autopsies. Lobular carcinoma in situ was generally seen only in association with infiltrating carcinoma, usually of the ductal type. No LCIS was seen in the breasts from random autopsies. These trends are the same if the proliferative lesions with severe atypia are included with carcinoma in situ. The numbers of lesions were also markedly greater in affected cancer-associated breasts than in affected breasts obtained from autopsies. These findings suggest that LCIS, although a rare lesion in the general population, may be a significant marker for clinical carcinoma. They support previous studies showing a small percentage of women with undetected DCIS of uncertain clinical and biological potential. The multicentric nature of preinvasive breast carcinoma is further substantiated. Finally, when the prevalence and number of lesions are considered in association with the ages of the patients, the lower prevalence of such lesions in the older patients in each sample suggests that at least some DCIS and LCIS may be dependent on a premenopausal hormonal milieu for their continuing existence.

摘要

采用亚大体抽样技术对292例人类乳腺进行了全乳检查,并经组织学证实。样本包括185例随机尸检的乳腺、63例含癌乳腺和44例含癌乳腺的对侧乳腺。该方法能够识别和计数每个乳腺中基本上所有的发育异常、增生和肿瘤性病变。重点在于每种样本类型中原位导管癌(DCIS)、小叶原位癌(LCIS)以及具有重度异型性的上皮增生性病变(以前称为ALA 4和ALB 4,分别对应临床病理实体非典型导管增生和非典型小叶增生)的患病率。在52.5%的含癌乳腺中发现了额外的DCIS原发性病灶(如果存在,与浸润性乳腺癌无关),在47.7%的对侧乳腺和5.9%的随机尸检乳腺中也可见到。小叶原位癌通常仅与浸润性癌相关,通常为导管型。在随机尸检的乳腺中未发现LCIS。如果将具有重度异型性的增生性病变与原位癌一起考虑,这些趋势是相同的。受累的癌相关乳腺中的病变数量也明显多于尸检获得的受累乳腺。这些发现表明,LCIS虽然在一般人群中是一种罕见病变,但可能是临床癌的重要标志物。它们支持了先前的研究,即显示有一小部分女性存在未被检测到的、临床和生物学潜能不确定的DCIS。乳腺浸润前癌的多中心性质得到了进一步证实。最后,当考虑病变的患病率和数量与患者年龄的关系时,每个样本中老年患者中此类病变的患病率较低,这表明至少一些DCIS和LCIS可能依赖于绝经前的激素环境才能持续存在。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验